Abstract 4574: Towards a new targeted therapy for ovarian cancer : Development of an anti-human müllerian inhibiting substance type II receptor humanized antibody
2012 ◽
2006 ◽
Vol 5
(8)
◽
pp. 2096-2105
◽
2011 ◽
2013 ◽
Vol 387
(1-2)
◽
pp. 11-20
◽
2018 ◽
Vol 59
(8)
◽
pp. 1234-1242
◽
2010 ◽
2016 ◽
Vol 16
(3)
◽
pp. 222-231
◽